
Daclatasvir (60mg)
Active composition
Daclatasvir inhibits the NS5A protein of the hepatitis C virus, disrupting the viral replication process and reducing viral load.
Medical applications
MYDACLA 60MG TABLET contains Daclatasvir as its active ingredient, offering a crucial component in the treatment of chronic hepatitis C virus (HCV) infection. This medication, when used in combination with other antiviral agents, helps to suppress HCV multiplication, reducing viral loads and aiding in the management of the disease. MYDACLA should be administered under medical supervision, as it is essential to monitor the treatment's progress and ensure optimal patient care. It is important to note that MYDACLA is not a cure for HCV but rather helps control the infection. Consult a healthcare provider for a thorough evaluation and guidance on the proper use of MYDACLA.
How to use Mydacla Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. MYDACLA 60MG TABLET may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is not known whether it is safe to consume alcohol with MYDACLA 60MG TABLET. Please consult your doctor.
High Risk
MYDACLA 60MG TABLET may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
It is not known whether MYDACLA 60MG TABLET alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
MYDACLA 60MG TABLET is safe to use in patients with liver disease. No dose adjustment of MYDACLA 60MG TABLET is recommended.
Regular Checkup
MYDACLA 60MG TABLET is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Consult Doctor
MYDACLA 60MG TABLET is safe to use in patients with kidney disease. No dose adjustment of MYDACLA 60MG TABLET is recommended.
Regular Checkup
0 reviews for MYDACLA 60MG TABLET

Daclatasvir (60mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Daclatasvir inhibits the NS5A protein of the hepatitis C virus, disrupting the viral replication process and reducing viral load.
Medical applications
MYDACLA 60MG TABLET contains Daclatasvir as its active ingredient, offering a crucial component in the treatment of chronic hepatitis C virus (HCV) infection. This medication, when used in combination with other antiviral agents, helps to suppress HCV multiplication, reducing viral loads and aiding in the management of the disease. MYDACLA should be administered under medical supervision, as it is essential to monitor the treatment's progress and ensure optimal patient care. It is important to note that MYDACLA is not a cure for HCV but rather helps control the infection. Consult a healthcare provider for a thorough evaluation and guidance on the proper use of MYDACLA.
How to use Mydacla Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. MYDACLA 60MG TABLET may be taken with or without food, but it is better to take it at a fixed time.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is not known whether it is safe to consume alcohol with MYDACLA 60MG TABLET. Please consult your doctor.
High Risk
MYDACLA 60MG TABLET may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
It is not known whether MYDACLA 60MG TABLET alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
MYDACLA 60MG TABLET is safe to use in patients with liver disease. No dose adjustment of MYDACLA 60MG TABLET is recommended.
Regular Checkup
MYDACLA 60MG TABLET is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Consult Doctor
MYDACLA 60MG TABLET is safe to use in patients with kidney disease. No dose adjustment of MYDACLA 60MG TABLET is recommended.
Regular Checkup
0 reviews for MYDACLA 60MG TABLET















